Edward M. Acton
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents 8
- Organic Chemistry top 2%
- Carbohydrate Chemistry and Synthesis 13
- Synthesis and biological activity 8
- Biophysics top 5%
- Oncology top 10%
- Cancer Treatment and Pharmacology 7
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 13
- Biochemical and Molecular Research 8
-
- Chemotherapy-induced cardiotoxicity and mitigation 7
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Leon GoodmanKenneth J. RyanGeorge L. TongDavid W. HenryCarol W. MosherAllan N. FujiwaraHsiao-Hsiung ChenJ. William Lown
- Partner nations
- United StatesCanadaCzechia
In The Last Decade
Edward M. Acton
70 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Toxicology 165
- Organic Chemistry 803
- Biophysics 97
- Oncology 377
- Molecular Biology 827
Countries citing papers authored by Edward M. Acton
This map shows the geographic impact of Edward M. Acton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Acton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Acton more than expected).
Fields of papers citing papers by Edward M. Acton
This network shows the impact of papers produced by Edward M. Acton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Acton. The network helps show where Edward M. Acton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward M. Acton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 0 | |
| 2 | 1994 | 107 | |
| 3 | 1990 | 7 | |
| 4 | 1986 | 6 | |
| 5 | Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro. | 1986 | 22 |
| 6 | Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat. | 1984 | 19 |
| 7 | 1983 | 18 | |
| 8 | 1981 | 4 | |
| 9 | 1979 | 60 | |
| 10 | 1978 | 3 | |
| 11 | 1975 | 30 | |
| 12 | 1974 | 33 | |
| 13 | 1969 | 3 | |
| 14 | 1967 | 7 | |
| 15 | 1967 | 6 | |
| 16 | 1966 | 29 | |
| 17 | 1964 | 24 | |
| 18 | 1964 | 29 | |
| 19 | 1963 | 3 | |
| 20 | 1957 | 4 |
About Edward M. Acton
Edward M. Acton is a scholar working on Toxicology, Organic Chemistry and Biophysics, having authored 72 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Carbohydrate Chemistry and Synthesis (13 papers), Bioactive Compounds and Antitumor Agents (8 papers), Synthesis and biological activity (8 papers), Biochemical and Molecular Research (8 papers), Cancer Treatment and Pharmacology (7 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Toxicology (165 citations), Organic Chemistry (803 citations) and Biophysics (97 citations). Edward M. Acton has collaborated with scholars based in United States, Canada and Czechia. Frequent co-authors include Leon Goodman, Kenneth J. Ryan, George L. Tong, David W. Henry, Carol W. Mosher, Allan N. Fujiwara, Hsiao-Hsiung Chen, J. William Lown, James A. Plambeck and Richard L. Wolgemuth.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.